Clinical Trial Update: A Safety and Effectiveness Study of JUVÉDERM VOLIFT® XC Versus Control for Moderate to Severe Nasolabial Folds [NA]

View source ↗

Summary

A completed clinical trial evaluating JUVÉDERM VOLIFT XC versus control for moderate to severe nasolabial folds with posted results in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Nasolabial Folds

Drugs mentioned

• JUVÉDERM VOLIFT XC (Hyaluronic Acid dermal filler (Juvéderm Volift XC))

Snippet

Sponsor: Allergan | Conditions: Moderate to Severe Nasolabial Folds | NA | Status: COMPLETED | Results posted: 2017-05-22